{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PRKN",
        "Protein_Change": {
          "ref": "Not specified",
          "alt": "Not specified",
          "position": "Not specified"
        },
        "variant_string_id": "PRKN NotSpecified"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin mutations associated with AR-JP abolish ubiquitin ligase activity, leading to loss of p53 repression and proteasome-resistant protein accumulation.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism: loss of parkin's ubiquitin ligase activity and p53 repression as central to AR-JP pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "ChIP experiments, p53 promoter transactivation assays, and p53 expression/mRNA level measurements were used.",
          "judgment": "Yes",
          "reasoning": "These assays (ChIP, promoter transactivation, and gene expression) directly assess parkin's transcriptional regulation of p53, a core disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Pathogenic mutations abolished DNA binding to and transactivation of p53. Controls included familial mutations preserving ligase activity.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly describe basic controls (wild-type vs. mutant) or replicate experiments. Variant controls (e.g., known pathogenic/benign) are implied but not detailed.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "ChIP and promoter transactivation are standard assays for assessing transcription factor-DNA interactions and gene regulation.",
          "judgment": "Yes",
          "reasoning": "ChIP and promoter transactivation are broadly accepted techniques in molecular biology.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Pathogenic mutations abolished p53 repression; no statistical OddsPath calculation or control variant counts are provided.",
          "judgment": "No",
          "reasoning": "No statistical analysis (p-values, effect sizes) or OddsPath calculation is reported. Control variant numbers are unspecified.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Control variant counts are unspecified in the abstract.",
          "judgment": "Yes",
          "reasoning": "Due to lack of control variant counts, the evidence is categorized as supporting.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    }
  ]
}